COMPOUNDS USEFUL AS MODULATORS OF THE PROTEASOME ACTIVITY

The present invention relates to the use of compounds of the following general formula (I): wherein no is 0 or 1, and when no is 1, X = CH2 or X = NCH2C6H5; R1 is OH, or a OR10 group, or a group of formula NH-(CH2)n1-R11; R2 is H, or an alkyl group, or a group of formula (CH2)n2-(CO)n3-NR13R14; R3 i...

Full description

Saved in:
Bibliographic Details
Main Authors PAGANO, MAURICE, BASSE, NICOLAS, PIGUEL, SANDRINE, FERRIER-BERTHELOT, ALEXANDRA, REBOUD-RAVAUX, MICHELE CLAUDE YVONNE, VIDAL, JOELLE
Format Patent
LanguageEnglish
French
Published 01.12.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the use of compounds of the following general formula (I): wherein no is 0 or 1, and when no is 1, X = CH2 or X = NCH2C6H5; R1 is OH, or a OR10 group, or a group of formula NH-(CH2)n1-R11; R2 is H, or an alkyl group, or a group of formula (CH2)n2-(CO)n3-NR13R14; R3 is H, or an alkyl group; R4 is H, or Boc, or Z; R5 is H, or Boc, or Z ; R6 is a OR16 group; R7 and R8 are H, or a halogen atom, as modulators of the proteasome activity, in the frame of the preparation of a medicament useful for the prevention or treatment of diseases wherein the proteasome is involved, or the preparation of cosmetic compositions, or of phytosanitary compositions.
Bibliography:Application Number: CA20052604133